Anti-PCK1 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | PCK1 |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Immunocytochemistry (1:100-1:250); Immunohistochemistry (1:100-1:250); Western Blot (1:600) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal(JU84-39) |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | cytosolic [GTP] antibody |
| GTP antibody | |
| PCK1 antibody | |
| PCKGC_HUMAN antibody | |
| PEP carboxykinase antibody | |
| PEPCK-C antibody | |
| PEPCK1 antibody | |
| PEPCKC antibody | |
| Phosphoenolpyruvate carboxykinase 1 (soluble) antibody | |
| Phosphoenolpyruvate carboxykinase 1 antibody | |
| Phosphoenolpyruvate carboxykinase antibody | |
| Phosphoenolpyruvate carboxykinase, cytosolic [GTP] antibody | |
| Phosphoenolpyruvate carboxykinase, cytosolic antibody | |
| Phosphoenolpyruvate carboxylase antibody | |
| Phosphopyruvate carboxylase antibody |
Show More
Target information
Regulates cataplerosis and anaplerosis, the processes that control the levels of metabolic intermediates in the citric acid cycle. At low glucose levels, it catalyzes the cataplerotic conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. At high glucose levels, it catalyzes the anaplerotic conversion of phosphoenolpyruvate to oxaloacetate.
Provider
Erpantech Laboratory
